(Q38061891)

28 August 2017

1 reference

title

Overlooked non-motor symptoms in myasthenia gravis (English)

1 reference

28 August 2017

0 references

0 references

2

Kimiaki Utsugisawa

1 reference

28 August 2017

Shigeaki Suzuki

1

1 reference

28 August 2017

Norihiro Suzuki

series ordinal

3

1 reference

28 August 2017

language of work or name

English

0 references

publication date

22 November 2012

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

28 August 2017

published in

1 reference

28 August 2017

volume

84

1 reference

28 August 2017

issue

9

1 reference

28 August 2017

page(s)

989-994

1 reference

Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Myasthenia and related disorders of the neuromuscular junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Thymoma in patients with MG: characteristics and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Thymoma and paraneoplastic myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Paraneoplastic diseases associated with thymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Late recurrent thymoma in myasthenia gravis: a case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

A SYNDROME OF CONTINUOUS MUSCLE-FIBRE ACTIVITY

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Clinical spectrum of voltage-gated potassium channel autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Morvan syndrome: clinical and serological observations in 29 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Acquired pure red cell aplasia: updated review of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Initial predictors of development of pure red cell aplasia in myasthenia gravis after thymectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Myasthenia gravis with thymus hyperplasia and pure red cell aplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Myasthenia gravis accompanied by alopecia areata: clinical and immunogenetic aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

A case of Good syndrome accompanied by myasthenia gravis: immunological evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Idiopathic giant cell polymyositis. Report of a case and review of the syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Autoimmune targets of heart and skeletal muscles in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Inflammatory myopathy in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Detecting sweet and umami tastes in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Concurrence of non-myasthenic symptoms with myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Aire and T cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

The role of T-cells in the initiation of autoantibody responses in thymoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Novel autoantibodies to a voltage-gated potassium channel KV1.4 in a severe form of myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

Taste disorders in myasthenia gravis: a multicenter cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304057

21 January 2018

Identifiers

DOI

10.1136/JNNP-2012-304057

1 reference

28 August 2017

1 reference